Kimia Biosciences MD, chairman, board of directors and AGM
BSE: 530313Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹30.05.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹142 Cr2,580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 19.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 8.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 51.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 19.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 1.95
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,361
Statutory auditor
Named in the results for the quarter to Mar 2026.
- NEERAJ ARORA & ASSOCIATESPeer-review certificate valid to Mar 2028
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Kimia Biosciences AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Kimia Biosciences share news and announcements
Annual general meeting, 28 Sep 2026
12,751 shareholders on the register on 21 Sep 2026; present: 2 promoters and 33 others; votes counted by MAYA SHARMA / M/s Maya Sharma & Associates.The company's voting result (opens in a new tab)
- To receive, consider and adopt the Audited Financial Statements for the year ended 31st March 2026, along with the Reports of the Directors' and Auditors' thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 82.52% · promoters 100.00% · institutions 0.00% · other public 30.73%
- Re appointment of Mr. Sameer Goel (DIN: 00161786), Director, who retires by rotation, and liable to retire by rotationOrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.08%
Turnout: all 82.52% · promoters 100.00% · institutions 0.00% · other public 30.73%
- To approve the remuneration of the Cost Auditors for the financial year ending 31st March, 2026.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.08%
Turnout: all 82.52% · promoters 100.00% · institutions 0.00% · other public 30.73%
- To approve appointment of Mr. Amulya Kumar Nayak (DIN: 11667557) as Director retire by rotation.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.08%
Turnout: all 82.52% · promoters 100.00% · institutions 0.00% · other public 30.73%
- To approve appointment of Ms. Reema Goyal (DIN: 11266730) as Independent & Non-Executive Woman DirectorOrdinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.08%
Turnout: all 82.52% · promoters 100.00% · institutions 0.00% · other public 30.73%
- To approve appointment of Mr. Avinash Prabhat (DIN:10997441) as Independent & Non-Executive Director.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.08%
Turnout: all 82.52% · promoters 100.00% · institutions 0.00% · other public 30.73%
- Approval for increasing the borrowing limit under section 180(1) (c) of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 82.52% · promoters 100.00% · institutions 0.00% · other public 30.73%
- To create mortgage and/or charge on all or any of the movable and/or immovable properties of the companySpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.08%
Turnout: all 82.52% · promoters 100.00% · institutions 0.00% · other public 30.73%
- Approval of loans, investments, guarantee or security u/s 185 of Companies Act, 2013Special99.84% for0.16% against
Against: promoters 0.00% · institutions 0.00% · other public 1.74%
Turnout: all 82.52% · promoters 100.00% · institutions 0.00% · other public 30.73%
Approval of Members for increase in the limits applicable for making investments / extending loans and giving guarantees or providing securities in connection with loans to Persons / Bodies Corporate u/s 186 of the Companies Act,2013.MoreLess
Special99.83% for0.17% againstAgainst: promoters 0.00% · institutions 0.00% · other public 1.82%
Turnout: all 82.52% · promoters 100.00% · institutions 0.00% · other public 30.73%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.